Deborah Meyran

Parkville, VIC, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Co-designing a Novel Ordinal Endpoint for an Adaptive Platform Trial, BANDICOOT, in Pediatric Hematopoietic Stem Cell Transplant.

Co-designing a Novel Ordinal Endpoint for an Adaptive Platform Trial, BANDICOOT, in Pediatric Hematopoietic Stem Cell Transplant.

Journal: Transplantation and cellular therapy
Published: December 20, 2024

Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors.

Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors.

Journal: Nature communications
Published: March 04, 2024

Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions.

Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 26, 2024

Infections in children following chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia.

Infections in children following chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia.

Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: September 12, 2023

A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

Journal: Haematologica
Published: August 17, 2023

TSTEM-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models.

TSTEM-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models.

Journal: Science translational medicine
Published: April 05, 2023

A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer.

A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer.

Journal: Genome medicine
Published: October 13, 2022

Advances in CAR T cell immunotherapy for paediatric brain tumours.

Advances in CAR T cell immunotherapy for paediatric brain tumours.

Journal: Frontiers in oncology
Published: February 20, 2022

Enhancing the Potential of Immunotherapy in Paediatric Sarcomas: Breaking the Immunosuppressive Barrier with Receptor Tyrosine Kinase Inhibitors.

Enhancing the Potential of Immunotherapy in Paediatric Sarcomas: Breaking the Immunosuppressive Barrier with Receptor Tyrosine Kinase Inhibitors.

Journal: Biomedicines
Published: November 08, 2021

The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cells.

The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cells.

Journal: Haematologica
Published: October 04, 2021

Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma.

Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma.

Journal: Cancers
Published: August 23, 2021

Early-phenotype CAR-T cells for the treatment of pediatric cancers.

Early-phenotype CAR-T cells for the treatment of pediatric cancers.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 13, 2021
Showing 1-12 of 19

Last Updated: 09/26/2026